ACTIVASE Side Effects

7003446-0 | Aortic Aneurysm Rupture
on Sep 14, 2010 Male patient from JAPAN , 83 years of age, was diagnosed with cerebral thrombosis and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: aortic aneurysm rupture. Activase dosage: 40 Ml, Qd. During the same period patient was treated with ARGATROBAN (40 Mg, Qd) (View Argatroban Review and Argatroban Label ), CILOSTAZOL (100 Mg, Qd) (View Cilostazol Review and Cilostazol Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), RADICUT (30 Mg, Bid) (View Radicut Review and Radicut Label ), PERINDOPRIL ERBUMINE (2 Mg, Qd) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), AMLODIPINE BESYLATE (5 Mg, Qd) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ).

6967604-3 | Hepatic Haemorrhage
Patient was taking Activase (View Usage). Patient had the following side effects: hepatic haemorrhage on Sep 02, 2010 from Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with cerebral infarction, cerebrovascular accident and. Activase dosage: . During the same period patient was treated with PERSANTIN (400 Mg) (View Persantin Review and Persantin Label ), ACETYLSALICYLIC ACID (80 Mg) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6963887-4 | Aortic Aneurysm Rupture
Adverse event was reported on Aug 30, 2010 by a Male patient taking Activase (View Usage) (Dosage: 40 Ml, Qd) was diagnosed with cerebral thrombosis, hyperlipidaemia and. Location: JAPAN , 83 years of age, After Activase was administered, patient had the following side effects: aortic aneurysm rupture. During the same period patient was treated with ARGATROBAN (Unk) (View Argatroban Review and Argatroban Label ), CILOSTAZOL (Unk) (View Cilostazol Review and Cilostazol Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), RADICUT (30 Mg, Bid) (View Radicut Review and Radicut Label ), ANGIOTENSIN CONVERTING ENZYME INHIBITOR NOS (View Angiotensin Converting Enzyme Inhibitor Nos Review and Angiotensin Converting Enzyme Inhibitor Nos Label ), VASODILATORS NOS (View Vasodilators Nos Review and Vasodilators Nos Label ).

6946167-2 | Aortic Aneurysm Rupture
on Aug 24, 2010 Male patient from JAPAN , 83 years of age, was diagnosed with cerebral thrombosis, hyperlipidaemia and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: aortic aneurysm rupture. Activase dosage: 40 Ml, Qd. During the same period patient was treated with RADICUT (30 Mg, Bid) (View Radicut Review and Radicut Label ), ARGATROBAN (Unk) (View Argatroban Review and Argatroban Label ), CILOSTAZOL (Unk) (View Cilostazol Review and Cilostazol Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), ANGIOTENSIN CONVERTING ENZYME INHIBITOR NOS (View Angiotensin Converting Enzyme Inhibitor Nos Review and Angiotensin Converting Enzyme Inhibitor Nos Label ), VASODILATORS NOS (View Vasodilators Nos Review and Vasodilators Nos Label ).


6914528-3 | Lip Swelling, Obstructive Airways Disorder, Swelling Face, Swollen Tongue
on Aug 05, 2010 Female patient from UNITED STATES , 75 years of age, weighting 176.4 lb, was diagnosed with cerebrovascular accident and was treated with Activase (View Usage). Patient had the following side effects: lip swelling, obstructive airways disorder, swelling face, swollen tongue. Activase dosage: 100 Mg Ot Iv. During the same period patient was treated with MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), SOMA (View Soma Review and Soma Label ), ALLEGRA (View Allegra Review and Allegra Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ).

6868639-1 | Cerebral Haemorrhage
Patient was taking Activase (View Usage). After Activase was administered, patient had the following side effects: cerebral haemorrhage on Jul 21, 2010 from UNITED STATES Additional patient health information: Female patient , 86 years of age, weighting 119.0 lb, was diagnosed with cerebrovascular accident and. Activase dosage: .

6861489-1 | Dizziness, Dysarthria, Dyspnoea, Hyperhidrosis, Hypotension, Infusion Related Reaction, Movement Disorder, Nausea, Tachycardia
Adverse event was reported on Jul 20, 2010 by a Male patient taking Activase (View Usage) (Dosage: 6.3mg Bolus Followed By 56.7 Mg Once Iv Drip) was diagnosed with cerebrovascular accident and. Location: UNITED STATES , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dysarthria, dyspnoea, hyperhidrosis, hypotension, infusion related reaction, movement disorder (What is movement disorder?), nausea (What is nausea?), tachycardia.

6856099-6 | Cerebrovascular Accident, Device Malfunction, Vomiting
on Jul 15, 2010 Male patient from UNITED STATES , 67 years of age, weighting 253.0 lb, was diagnosed with thrombosis in device and was treated with Activase (View Usage). Patient had the following side effects: cerebrovascular accident, device malfunction, vomiting. Activase dosage: 30mg And 10 Mg At 3 Mg/hr Continuous Iv Drip. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), HEPARIN (View Heparin Review and Heparin Label ), ALBUTEROL NEB SOLUTION (View Albuterol Neb Solution Review and Albuterol Neb Solution Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ).

6736280-7 | Disseminated Intravascular Coagulation, Shock
on May 17, 2010 Female patient from JAPAN , 86 years of age, was diagnosed with cerebral artery embolism and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: disseminated intravascular coagulation, shock. Activase dosage: .

6704299-8 | Aortic Dissection
Patient was taking Activase (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dissection on Apr 26, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with cerebral infarction and. Activase dosage: 0.6 Mg/kg, Unk.

6691000-X | Anaphylactic Reaction
Adverse event was reported on Apr 15, 2010 by a Female patient taking Activase (View Usage) (Dosage: 24000000 Iu, Qd) was diagnosed with embolic stroke and. Location: JAPAN , 79 years of age, Patient had the following side effects: anaphylactic reaction. During the same period patient was treated with RADICUT (Unk) (View Radicut Review and Radicut Label ).

6690088-X | Glaucoma
on Apr 14, 2010 Female patient from GERMANY , 57 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: glaucoma (What is glaucoma?). Activase dosage: .

6690086-6 | Disease Recurrence, Macular Oedema
on Apr 14, 2010 Female patient from GERMANY , 72 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: disease recurrence, macular oedema. Activase dosage: .

6690064-7 | Disease Recurrence, Macular Oedema
Patient was taking Activase (View Usage). Patient had the following side effects: disease recurrence, macular oedema on Apr 14, 2010 from GERMANY Additional patient health information: Male patient , 53 years of age, was diagnosed with retinal vein occlusion and. Activase dosage: .

6689279-3 | Disease Recurrence, Macular Oedema
Adverse event was reported on Apr 14, 2010 by a Female patient taking Activase (View Usage) (Dosage: ) was diagnosed with retinal vein occlusion and. Location: GERMANY , 66 years of age, After Activase was administered, patient had the following side effects: disease recurrence, macular oedema.

6686688-3 | Blood Pressure Decreased, Blood Pressure Systolic Increased, Bradyarrhythmia, Convulsion, Feeling Hot, Incontinence, Loss Of Consciousness, Respiratory Depression, Ventricular Tachycardia
on Apr 16, 2010 Female patient from UNITED STATES , 63 years of age, weighting 216.1 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, blood pressure systolic increased, bradyarrhythmia, convulsion, feeling hot, incontinence, loss of consciousness, respiratory depression, ventricular tachycardia. Activase dosage: 100 Mg Once Iv 11:25 Am.

6679717-4 | Ischaemic Stroke
on Apr 07, 2010 Female patient from SINGAPORE , 65 years of age, was diagnosed with retinal artery occlusion and was treated with Activase (View Usage). Patient had the following side effects: ischaemic stroke. Activase dosage: .

6662405-8 | Glaucoma
Patient was taking Activase (View Usage). After Activase was administered, patient had the following side effects: glaucoma (What is glaucoma?) on Jan 19, 2010 from GERMANY Additional patient health information: Female patient , 57 years of age, was diagnosed with retinal vein occlusion and. Activase dosage: .

6662402-2 | Disease Recurrence, Macular Oedema
Adverse event was reported on Jan 19, 2010 by a Female patient taking Activase (View Usage) (Dosage: ) was diagnosed with retinal vein occlusion and. Location: GERMANY , 72 years of age, Patient experienced the following unwanted or unexpected effects: disease recurrence, macular oedema.

6662295-3 | Disease Recurrence, Macular Oedema
on Jan 19, 2010 Female patient from GERMANY , 66 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). Patient had the following side effects: disease recurrence, macular oedema. Activase dosage: .

6662284-9 | Disease Recurrence, Macular Oedema
on Jan 19, 2010 Male patient from GERMANY , 53 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: disease recurrence, macular oedema. Activase dosage: .

6609083-1 | Haemorrhage
Patient was taking Activase (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage on Feb 16, 2010 from GERMANY Additional patient health information: Male patient , 65 years of age, was diagnosed with ischaemic stroke and. Activase dosage: 60 Mg, Unk.

6590951-4 | Glaucoma
Adverse event was reported on Feb 12, 2010 by a Male patient taking Activase (View Usage) (Dosage: 125 A?g, Unk) was diagnosed with retinal vein occlusion and. Location: GERMANY , 68 years of age, Patient had the following side effects: glaucoma (What is glaucoma?).

6589022-2 | Glaucoma
on Feb 12, 2010 Male patient from GERMANY , 66 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: glaucoma (What is glaucoma?). Activase dosage: 125 A?g, Unk.

6589018-0 | Corneal Oedema, Glaucoma, Vitreous Haemorrhage
on Feb 12, 2010 Male patient from GERMANY , 58 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: corneal oedema, glaucoma (What is glaucoma?), vitreous haemorrhage. Activase dosage: 125 A?g, Unk.

6588701-0 | Aortic Aneurysm Rupture, Aortitis, Cardiac Arrest, Cardiac Failure, Cardiogenic Shock, Haemorrhage
Patient was taking Activase (View Usage). Patient had the following side effects: aortic aneurysm rupture, aortitis, cardiac arrest (What is cardiac arrest?), cardiac failure, cardiogenic shock, haemorrhage on Feb 10, 2010 from GERMANY Additional patient health information: Male patient , 50 years of age, was diagnosed with acute myocardial infarction and. Activase dosage: Unk.

6578647-6 | Anaphylactic Shock, Blood Pressure Immeasurable, Coma, Haemorrhage Intracranial, Muscle Spasms, Pulmonary Embolism
Adverse event was reported on Feb 03, 2010 by a Female patient taking Activase (View Usage) (Dosage: 50 Mg, Unk) was diagnosed with ischaemic stroke and. Location: GERMANY , 55 years of age, weighting 79.37 lb, After Activase was administered, patient had the following side effects: anaphylactic shock, blood pressure immeasurable, coma, haemorrhage intracranial, muscle spasms, pulmonary embolism (What is pulmonary embolism?).

6567070-6 | Anaphylactic Shock, Blood Pressure Immeasurable, Coma, Haemorrhage Intracranial, Muscle Spasms, Pulmonary Embolism
on Jan 22, 2010 Female patient from GERMANY , 55 years of age, weighting 79.37 lb, was diagnosed with ischaemic stroke and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, blood pressure immeasurable, coma, haemorrhage intracranial, muscle spasms, pulmonary embolism (What is pulmonary embolism?). Activase dosage: 50 Mg, Unk.

6565846-2 | Glaucoma
on Jan 19, 2010 Male patient from GERMANY , 68 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?). Activase dosage: Unk Ml, Unk.

6565532-9 | Acute Myocardial Infarction
Patient was taking Activase (View Usage). After Activase was administered, patient had the following side effects: acute myocardial infarction on Jan 27, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with cerebral artery embolism and. Activase dosage: 24.4 Ml, Qd. During the same period patient was treated with RADICUT (30 Mg, Bid) (View Radicut Review and Radicut Label ), OMEPRAL (20 Mg, Bid) (View Omepral Review and Omepral Label ).

6565072-7 | Corneal Oedema, Glaucoma, Vitreous Haemorrhage
Adverse event was reported on Jan 19, 2010 by a Male patient taking Activase (View Usage) (Dosage: 0.5 Ml, Unk) was diagnosed with retinal vein occlusion and. Location: GERMANY , 58 years of age, Patient experienced the following unwanted or unexpected effects: corneal oedema, glaucoma (What is glaucoma?), vitreous haemorrhage.

6559173-7 | Glaucoma
on Jan 19, 2010 Male patient from GERMANY , 66 years of age, was diagnosed with retinal vein occlusion and was treated with Activase (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?). Activase dosage: 0.5 Ml Of 25 Mcg/0.1 Ml.

6557124-2 | Cardiovascular Disorder
on Jan 21, 2010 Male patient from GERMANY , 74 years of age, was diagnosed with ischaemic stroke and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: cardiovascular disorder. Activase dosage: Unk.

6549846-4 | Visual Acuity Reduced
Patient was taking Activase (View Usage). Patient experienced the following unwanted or unexpected effects: visual acuity reduced on Jan 18, 2010 from GERMANY Additional patient health information: Male patient , 84 years of age, was diagnosed with retinal haemorrhage and. Activase dosage: 50 A?g, Single. During the same period patient was treated with SULFUR HEXAFLUORIDE GAS (0.3-0.4 Ml, Single) (View Sulfur Hexafluoride Gas Review and Sulfur Hexafluoride Gas Label ), BETADINE (Unk) (View Betadine Review and Betadine Label ).

6549844-0 | Visual Acuity Reduced
Adverse event was reported on Jan 18, 2010 by a Male patient taking Activase (View Usage) (Dosage: 25 A?g, Single) was diagnosed with retinal haemorrhage and. Location: GERMANY , 51 years of age, Patient had the following side effects: visual acuity reduced. During the same period patient was treated with SULFUR HEXAFLUORIDE GAS (0.3-0.4ml) (View Sulfur Hexafluoride Gas Review and Sulfur Hexafluoride Gas Label ), BETADINE (Unk, Unk) (View Betadine Review and Betadine Label ).

6547591-2 | Visual Acuity Reduced
on Jan 18, 2010 Male patient from GERMANY , 82 years of age, was diagnosed with retinal haemorrhage and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: visual acuity reduced. Activase dosage: 25 A?g, Single. During the same period patient was treated with SULFUR HEXAFLUORIDE GAS (0.3- 0.4 Ml, Single) (View Sulfur Hexafluoride Gas Review and Sulfur Hexafluoride Gas Label ), BETADINE (Unk, Unk) (View Betadine Review and Betadine Label ).

6547586-9 | Endophthalmitis, Eye Infection Bacterial
on Jan 18, 2010 Male patient from GERMANY , 87 years of age, was diagnosed with retinal haemorrhage and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis, eye infection bacterial. Activase dosage: 50 A?g, Single. During the same period patient was treated with PERFLUOROPROPANE (0.3-0.4 Ml, Single) (View Perfluoropropane Review and Perfluoropropane Label ), BETADINE (Unk, Unk) (View Betadine Review and Betadine Label ). Patient was hospitalized.

6547456-6 | Vitreous Haemorrhage
Patient was taking Activase (View Usage). Patient had the following side effects: vitreous haemorrhage on Jan 18, 2010 from GERMANY Additional patient health information: Female patient , 50 years of age, was diagnosed with retinal haemorrhage and. Activase dosage: 50 A?g, Single. During the same period patient was treated with SULFUR HEXAFLUORIDE GAS (0.3-0.4 Ml, Single) (View Sulfur Hexafluoride Gas Review and Sulfur Hexafluoride Gas Label ), BETADINE (Unk %, Unk) (View Betadine Review and Betadine Label ).

6545894-9 | Disseminated Intravascular Coagulation, Mental Status Changes, Sepsis
Adverse event was reported on Jan 11, 2010 by a Male patient taking Activase (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: GERMANY , 48 years of age, After Activase was administered, patient had the following side effects: disseminated intravascular coagulation, mental status changes, sepsis (What is sepsis?). Patient was hospitalized.

6542503-X | Hyperphosphataemia
on Jan 12, 2010 Female patient from UNITED STATES , weighting 61.73 lb, was diagnosed with medical device complication and was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: hyperphosphataemia. Activase dosage: 1.7 Mg, ^m,w,f^. Patient was hospitalized.

6536927-4 | Embolism, Ischaemic Stroke, Shock
on Jan 04, 2010 Male patient from GERMANY , 66 years of age, was diagnosed with myocardial infarction, sedation and was treated with Activase (View Usage). Patient had the following side effects: embolism, ischaemic stroke, shock. Activase dosage: 100 Mg, Unk. During the same period patient was treated with ACETYLSALICYLIC ACID (500 Mg, Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), UNFRACTIONATED HEPARIN (5000 U, Unk) (View Unfractionated Heparin Review and Unfractionated Heparin Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (6 G, Tid) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), PROPOFOL (100 Unk, Unk) (View Propofol Review and Propofol Label ).

6532266-6 | Abortion Missed, Haemoglobin Decreased, Subcutaneous Haematoma
Patient was taking Activase (View Usage). After Activase was administered, patient had the following side effects: abortion missed, haemoglobin decreased, subcutaneous haematoma on Dec 30, 2009 from GERMANY Additional patient health information: Female patient , 26 years of age, was diagnosed with thrombosis, superior vena caval occlusion and. Activase dosage: 0.05 Unk, Unk. During the same period patient was treated with HEPARIN (35000 U, Qd) (View Heparin Review and Heparin Label ).

6530441-8 | Respiratory Failure, Status Epilepticus
Adverse event was reported on Dec 28, 2009 by a Female patient taking Activase (View Usage) (Dosage: 20 Mg, Unk) was diagnosed with cerebral venous thrombosis and. Location: GERMANY , 49 years of age, Patient experienced the following unwanted or unexpected effects: respiratory failure, status epilepticus. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6512413-2 | Blood Pressure Inadequately Controlled, Haemorrhage Intracranial
on Dec 12, 2009 Male patient from CHINA , 70 years of age, was diagnosed with ischaemic stroke and was treated with Activase (View Usage). Patient had the following side effects: blood pressure inadequately controlled, haemorrhage intracranial. Activase dosage: 0.9 Mg/kg, Unk. Patient was hospitalized.

6489568-1 | Cerebral Haemorrhage, Coma, Paresis, Pneumonia, Somnolence, Status Epilepticus, Vomiting
on Dec 02, 2009 Female patient from GERMANY , weighting 136.7 lb, was diagnosed with cerebrovascular accident, coronary artery disease (What is coronary artery disease?), atrial fibrillation (What is atrial fibrillation?) and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: cerebral haemorrhage, coma, paresis, pneumonia (What is pneumonia?), somnolence, status epilepticus, vomiting. Activase dosage: 56 Mg, Unk. During the same period patient was treated with TICLOPIDINE HCL (250 Mg, Qd) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), BISOPROLOL (10 Mg, Unk) (View Bisoprolol Review and Bisoprolol Label ), FENOFIBRAT (250 Mg, Unk) (View Fenofibrat Review and Fenofibrat Label ), MAGNESIUM (Unk) (View Magnesium Review and Magnesium Label ), DUOTRAV (Unk) (View Duotrav Review and Duotrav Label ).

6489567-X | Acute Myocardial Infarction, Cerebral Haemorrhage
Patient was taking Activase (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, cerebral haemorrhage on Dec 03, 2009 from JAPAN Additional patient health information: Male patient , 62 years of age, was diagnosed with cerebral infarction and. Activase dosage: Unk. Patient was hospitalized.

6479500-9 | Dyspnoea, Flushing
Adverse event was reported on Dec 07, 2009 by a Male patient taking Activase (View Usage) (Dosage: Pre/post Treatment Iv Drip) was diagnosed with sickle cell anaemia and. Location: UNITED STATES , 27 years of age, Patient had the following side effects: dyspnoea, flushing.

6470078-2 | Acute Myocardial Infarction, Cerebral Haemorrhage
on Nov 30, 2009 Male patient from JAPAN , 62 years of age, was diagnosed with cerebral infarction and was treated with Activase (View Usage). After Activase was administered, patient had the following side effects: acute myocardial infarction, cerebral haemorrhage. Activase dosage: . Patient was hospitalized.

6456778-9 | Bradycardia, Drooling, Hypotension, Snoring, Unresponsive To Stimuli
on Nov 24, 2009 Male patient from UNITED STATES , 89 years of age, was treated with Activase (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, drooling, hypotension, snoring (What is snoring?), unresponsive to stimuli. Activase dosage: . During the same period patient was treated with LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ).

6452042-2 | Intracranial Pressure Increased
Patient was taking Activase (View Usage). Patient had the following side effects: intracranial pressure increased on Oct 29, 2009 from GERMANY Additional patient health information: Male patient , child 5 years of age, was diagnosed with cerebral venous thrombosis and. Activase dosage: Unk.